Altimmune (ALT) Interest Expenses (2010 - 2026)
Altimmune (ALT) reported Interest Expenses of $1.1 million for Q1 2026, up 106700.0% year-over-year from N/an in Q1 2025, and up 21.92% quarter-over-quarter from $876000.0 in Q4 2025.
Altimmune (ALT) Interest Expenses (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Interest Expenses data on file, last reported at $1.1 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $1.1 million, up 106700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 29933.33% YoY), and the FY2025 annual result was $1.6 million, up 18077.78% from the prior year.
- Interest Expenses rose to $1.1 million in Q1 2026 per ALT's latest filing, from $876000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $1.1 million in Q1 2026 and troughed at -$183000.0 in Q4 2022.
- A 5-year average of $162117.6 and a median of $6000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2026: Interest Expenses slumped 195.16% in 2022, then jumped 106700.0% in 2026.
- A 5-year view of Interest Expenses shows it stood at -$183000.0 in 2022, then jumped by 101.09% to $2000.0 in 2023, then sank by 50.0% to $1000.0 in 2024, then jumped by 87500.0% to $876000.0 in 2025, then increased by 21.92% to $1.1 million in 2026.
- Business Quant data shows ALT's Interest Expenses at $1.1 million in Q1 2026, $876000.0 in Q4 2025, and $495000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 876,000.00 |
| Dec 31, 2025 | 876,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |